Inhibition of NF-κB by MG132 through ER stress-mediated induction of LAP and LIP

FEBS Lett. 2011 Jul 21;585(14):2249-54. doi: 10.1016/j.febslet.2011.05.047. Epub 2011 May 27.

Abstract

Proteasome inhibitor MG132 blocks activation of NF-κB by preventing degradation of IκB. In this report, we propose an alternative mechanism by which MG132 inhibits cytokine-triggered NF-κB activation. We found that MG132 induced endoplasmic reticulum (ER) stress, and attenuation of ER stress blunted the suppressive effect of MG132 on NF-κB. Through ER stress, MG132 up-regulated C/EBPβ mRNA transiently and caused sustained accumulation of its translational products liver activating protein (LAP) and liver-enriched inhibitory protein (LIP), both of which were identified as suppressors of NF-κB. Our results disclosed a novel mechanism underlying inhibition of NF-κB by MG132.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • CCAAT-Enhancer-Binding Protein-beta / metabolism*
  • Cell Line
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Endoplasmic Reticulum / metabolism*
  • Leupeptins / metabolism
  • Leupeptins / pharmacology*
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Rats
  • Stress, Physiological*
  • Transcriptional Activation*
  • Unfolded Protein Response

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • Cysteine Proteinase Inhibitors
  • Leupeptins
  • NF-kappa B
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde